Perbedaan Ekspresi Reseptor Estrogen Dan Reseptor Progesteron Pada Jaringan Mioma Dan Miometrium Normal

  DAFTAR PUSTAKA 1. Leppert P, Fouany M, Segars JH. Understanding Uterine Fibroids.

  In: Gynecology in Practice. Wiley-Blackwell, Oxford. 2013

  2. Bulun SE. Uterine Fibroids, mechanisms of disease. N engl j med 2013; 369(14): 1344-55 3. Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P.

  The Genetic Bases of Uterine Fibroids; A Review. J Reprod Infertil. 2011;12(3):181-191 4. Wiknjosastro H, Saifuddin AB, Rachimhadhi T. Ilmu Kandungan.

  Edisi II. PT. Bina Pustaka Sarwono Prawirohardjo. Jakarta. 2008: 73 – 90; 338 – 345.

  5. Pratiwi L, Suparman E, Wagey F. Hubungan Usia Reproduksi Dengan Kejadian Mioma Uteri Di RSUP. Prof. Dr. R.D. Kandou Manado. Jurnal e-CliniC (eCl). 2013;1(1): 26-30

  6. Ginting LY, Rasmaliah, Jemadi. Karakteristik Penderita Mioma Uteri Yang Di Rawat Inap Di RSUD dr. Pirngadi Medan Tahun 2009-2011. Fakultas Kesehatan Masyarakat Universitas Sumatera Utara. 2012

  7. Northington GM, Arya LA. Uterine Leiomyoma. Obstetric and Gynecology Board Review Manual. 2006;10: 1-12

  8. Sozen I, Arici TA. Cellular Biology of Myomas: Interaction of Sex Steroids with Cytokines and Growth Factors. Obstet Gynecol Clin N Am. 2006;33: 41– 58

  9. Ikbal MN . Prevalensi Anemia Pada Penderita Mioma Uteri di RSUP

  H. Adam Malik Medan Tahun 2010. Karya Tulis Ilmiah. Fakultas

  2011 Kedokteran Universitas Sumatera Utara.

  10. Villanova FE, Andrade PM, Otsuka AY, Gomes MTV, Leal ES, et al.

  Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids. 2006;71:960–965

  11. Ciarmela P, Islam S, Reis FM, Gray PC, Bloise E, et al.Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Human Reproduction Update, 2011;17(6): 772–790

  12. Flake GP, Andersen J, Dixon D. Etiology and Pathogenesis of Uterine Leiomyomas: A Review. Environ Health Perspect. 2003; 111(8):1037–1054

  13. Sankaran S, Manyonda IT. Medical management of fibroids. Best Practice & Research Clinical Obstetrics and Gynaecology.

  2008;4(22):655–676 14. Wango EO, Tabifor HN, Muchiri LW, Kigondu CS, Makawiti DW. Progesterone, Estradiol And Their Respective Receptors In Leiomyoma And Adjacent Normal Myometria of Black Kenyan Women. African Journal of Health Sciences. 2002;3-4(9): 123-28 15. Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjoblom P, et al. Sex Steroid Receptors in Human Myometrium and Fibroids: Changes during the Menstrual Cycle and Gonadotropin-Releasing Hormone Treatment. J Clin Endocrinol Metab. 1998;83:4092–4096 16. Benassayag C, Leroy MJ, Rigourd V, Robert B, Honore JC, et al. Estrogen receptors (ERalpha/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol, 1999;276:E1112–E1118.

  17. Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, et al.

  Estrogen receptor a and b in uterine fibroids: a basis for altered estrogen responsiveness. Fertility and Sterility, 2008;3(2):1-8

  18. Grings AO, Lora V, Ferreira GD, Brum IS, Corleta HE, et al. Protein Expression of Estrogen Receptors

  α and β and Aromatase in Myometrium and Uterine Leiomyoma. Gynecol Obstet Invest. 2012;73:113–117 19. Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M, et al. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Human Reproduction, 1999;14(11):2844-2850

  20. Hodge JC, Morton CC. Uterine Leiomyomata : Aspects in Reproduction, Susceptibility, abd Tumor Cytogenetics. Madame Curie Report, Landes Bioscience. 2005

  21. Payson M, Leppert P, Segars J. Epidemiology of Myomas. Obstet Gynecol Clin N Am, 2006;33: 1-11

  22. Speroff L, Fritz, MA. The Uterus. In: Clinical Gynecologic

  th Endocrinology and Infertility. 8 ed. Lippincott Williams & Wilkins.

  North Carolina. 2011: 148-55

  23. Gibs RS, Karlan BY, Haney AF, Nygaard IE. Danforth’s Obstetrics

  th

and Gynecologic. 10 Ed. Lippincolt Williams and Wilkins. 2008 :

1003 – 6; 917 – 929.

  24. Davis PC, et all. Sonohysterographic Findings of Endometrial and Subendometrial Conditions. 2002;4(22):10-16

  25. Schorge JO, Schaffler JI, Halvorson LM, Hoffman BL, Bradshaw

  st KD, et all. Williams gynecology. 1 Ed. McGraw-Hill Companies.

  2008.

  26. DeCherney AH, Nathan L. Goodwin TM, Laufer N. Current

  

Diagnosis and Treatements in Obstetrics and Gynecology : Benign

th Disorders of the Uterine Corpus. 10 Ed. McGraw-Hill. 2007.

  27. Lumsden MA. Dewhurts Text book of Obstetrics and Gynaecology :

  th Benign disease of the uterus. 7 Ed. Blackwell publishing.

  Massachusetts, 2007: 636 – 644.

  28. Katz VL. Benign Gynecologic Lesions : Vulva, Vagina, Cervix,

  th Uterus, Oviduct, Ovary. In: Comprehensive Gynecology, 5 ed.

  Mosby Elsevier Inc. 2007

  29. Speroff L, Fritz, MA. Hormone Biosynthesis, Metabolisme, and Mechanism of Action. In: Clinical Gynecologic Endocrinology and

  th

  Infertility. 8 ed. Lippincott Williams & Wilkins. North Carolina. 2011: 29-55

  30. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Human Reproduction Update, 2004; 3(10): 207-220 31. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, et al. Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell. Mol. Life Sci. (2009) 66:2405–2426

  32. Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, et al.

  Estrogen receptor alpha (ER- α) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to mathed myometrium. Virchow Arch 2008; 453: 557 – 569

  33. Prabin S, Isha S, KaoruK. Immunohistochemistry: A Review of Practical Procedure.Nepal Journal of Neuroscience 2009; 6:38-41

  34. Lee A. Immunohistochemistry for Oestrogen and Progesterone Receptors. Connection, 2008:31-33

  35. Allred C. Assessment of Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry. Connection 9, 2006:4-5

  36. Kim EH, Kim JY, Lee YH, Chong GO, Park JY, et al. Comparison of estrogen receptor- α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids. Obstet Gynecol Sci. 2014;57(2):144- 150

  37. Dako. ER/PR PharmDx Interpretation Manual. Nov 2007;28252:1-

  23 38. Lessl M, Klotzbuecher M, Schoen S, Reles A, Stockemann K, et al. Comparative Messenger Ribonucleic Acid Analysis of Immediate Early Genes and Sex Steroid Receptors in Human Leiomyoma and Healthy Myometrium. J Clin Endocrinol Metab, 1997; 82: 2596– 2600

  39. Barbosa LF. Epidemiological factors associated with Uterine Fibroids. Universidade Da Beira Interior. 2012

  40. Gowri M, Mala G, Murthy S, Nayak V. Clinicopathological study of uterine leiomyomas in hysterectomy specimens. Journal of Evolution of Medical and Dental Sciences 2013; 2(46):9002-9009 41. Ofori EK, Asante M, Antwi WK, Coleman J, Brakohiapa EK, et al. Relationship Between Obesity And Leiomyomas Among Ghanaian Women. Journal of Medical and Applied Biosciences. 2012;4:14-25

  42. Olotu, EJ, Osunwoke EA, Ugboma HA, Odu, KN. Age prevalence of uterine fibroids in south-southern Nigeria: A retrospective study.

  Scientific Research and Essay 2008;3(9):457-459 43. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women’s Health 2012;12(6):1-12

  44. Wibowo MW. Gambaran Hiperplasia Endometrium pada Kasus Mioma Uteri di RSUP H. Adam Malik Medan. Tesis. Departemen Obstetri dan Ginekologi Fakultas Kedokteran Universitas Sumatera Utara. 2013

  45. He Y, Zeng Q, Dong S, Qin L, Li G, et al. Associations between uterine fibroids and lifestyles including diet, physical activity and stress: a case-control study in China. Asia Pac J Clin Nutr 2013;22(1):109-117-109

  46. Chen CR, Buck GM, Courey NG, Perez KM, Wende JW. Risk factors for uterine fibroids among woman undergoing tubal sterilization. A merican Journal of Epidemiology 2001; 153(1):20-26

  47. Parker WH. Etiology, Symptomatology, and Diagnosis of Uterine Myomas. Fertility and Sterility 2007;87(4):725

  48. Ibrar F, Riaz S, Dawood NS, Jabeen A. Frequency Of Fibroid Uterus In Multipara Women In A Tertiary Care Centre In Rawalpindi. J Ayub Med Coll Abbottabad 2010;22(3);155-157

  49. Lee EJ, Bajracharya P, Lee DM, Cho KH, Kim KJ, et al. Gene Expression Profiles of Uterine Normal Myometrium and Leiomyoma and Their Estrogen Responsiveness In Vitro. The Korean Journal of Pathology 2010; 44: 272-83 50. Asada H, Yamagata Y, Taketani T, Matsuoka A, Tamura H, et al.

  Potential link between estrogen receptor-a gene hypomethylation and uterine fibroid formation. Molecular Human Reproduction 2008;14(9):539–545 51. Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, et al. Progesterone Receptor Regulates Bcl-2 Gene Expression through Direct Binding to Its Promoter Region in Uterine Leiomyoma Cells. The Journal of Clinical Endocrinology & Metabolism 2007;92(11):4459–4466

  52. Garget CE, Bucak K, Zaitseva M, Chu S, Taylor N, et al. Estrogen receptor- α and –β expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Molecular

  Human Reproduction. 2002;8(8):770-775.